Some prefer the once-weekly simplicity
--- FAQ: GHK-Cu and the FDA Category 2 Removal Is GHK-Cu now FDA-approved
Theoretically, BPC-157 shows faster onset (4-6 days in animal models vs 2-6 weeks for human SSRIs), multi-system modulation rather than single-target effects, actual neuronal repair and regeneration (neuroprotection), no withdrawal syndrome in animals, and efficacy when given peripherally without extensive blood-brain barrier crossing
2-(2-Cholesteroxyethoxyl)ethyl 3-S-glutathionylpropionate and its self-assembled micelles for brain delivery: Design, synthesis and evaluation
Wound Healing and Recovery This peptide has been shown to accelerate tissue repair , making it ideal for those recovering from surgery, injury, or skin damage
Seal the bottle tightly after use